Lua Labs Report — Progesterone vs cortisol: competition and co-signaling at the glucocorticoid receptor (GR) and luteal consequences

New proposed hypothesis: H15 — "GR as a cycle-phase sensor: the receptor changes partners (P4 ↔ cortisol), and active cortisol availability determines whether the luteal phase matures or aborts"

Verified external sources

Hagan CR, Knutson TP, Lange CA (2013, analysis updated 2019). "A common docking domain in progesterone receptor-B links DUSP6 and MAPKs to delineate progesterone receptor isoform-specific cell migration" → followed by Lange lab — McGowan et al., 2019. "The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells." Nucleic Acids Research 47(20):10645-10661. DOI: 10.1093/nar/gkz857. PMID: 31598698. PMC: PMC6846950. — Documents that GR and PR share ~90% identity in the DBD and ~55% in the LBD; overlapping genomic binding sites; in the presence of dexamethasone (DEX), GR antagonizes PR-dependent regulation of pro-proliferative genes (ELF5, GREB1) and potentiates a subset (SNAI1, STAT5A). Crosstalk occurs at the chromatin level, not only through ligand competition.
Diep CH, Daniel AR, Mauro LJ, Knutson TP, Lange CA (2022). "Choosing the right partner in hormone-dependent gene regulation: glucocorticoid and progesterone receptors crosstalk in breast cancer cells." Frontiers in Endocrinology 13:1037177. DOI: 10.3389/fendo.2022.1037177. PMC: PMC9672667. — Integrative review of the "tethered/composite/assisted loading" model for GR-PR crosstalk. Documents that cross-ligand co-activation generates GR-PR complexes physically bound to DNA with their own transcriptional repertoire, distinct from either receptor alone.
Johannsen TH, Anand-Ivell R, Yding Andersen C, et al. (2024). "The intrafollicular concentrations of biologically active cortisol in women rise abruptly shortly before ovulation and follicular rupture." Human Reproduction 39(3):578-585. DOI: 10.1093/humrep/dead269. PMID: 38268234. — In L2.2 this citation was tentatively attributed to "Park 2023/2024". Correction: the main group is Johannsen et al. from Copenhagen, not Park; results remain intact. The mid-cycle hCG/LH surge reverses the HSD11B2/HSD11B1 ratio in granulosa (follicular HSD11B2 predominance → peri-ovulatory HSD11B1 predominance), producing bioactive intrafollicular cortisol that is now an obligatory physiological signal for the ovulatory cascade, not a pathological marker.
Webster SP, Ricketts ML, Anastassiades K, Walker BR, Stewart PM, Mason JI (2003). "Expression of 11β-hydroxysteroid dehydrogenase (11βHSD) proteins in luteinizing human granulosa-lutein cells." J Clin Endocrinol Metab. PMID: 12844344. — Establishes bidirectionality: follicular granulosa expresses HSD11B2 (inactivates cortisol→cortisone, "protects" maturation); luteinized granulosa switches to dominant HSD11B1 expression (reactivates cortisone→cortisol). The corpus luteum operates in "cortisol-permissive mode" from its formation.
Michael AE, Pester LA, Curtis P, Shaw RW, Edwards CR, Cooke BA (1996). "Direct inhibition of ovarian steroidogenesis by cortisol and the modulatory role of 11β-hydroxysteroid dehydrogenase." Clin Endocrinol (Oxf) 45(1):85-94. PMID: 8778220. + Michael et al. (2003) "Ovarian modulators of type 1 11β-hydroxysteroid dehydrogenase (11βHSD) activity and intra-follicular cortisol:cortisone ratios correlate with the clinical outcome of IVF." Hum Reprod. PMID: 12871869. — Clinical finding: the intrafollicular cortisol:cortisone ratio correlates with IVF outcome. "Moderate" ratios (functional but not exaggerated HSD11B1) are associated with higher pregnancy rate; extreme ratios in both directions are associated with worse outcome.
Wu Y, Li P, Zhang D, Sun Y (2016). "Local regeneration of cortisol by 11β-HSD1 contributes to insulin resistance of the granulosa cells in PCOS." J Clin Endocrinol Metab 101(7):2932-2940. DOI: 10.1210/jc.2016-1404. PMID: 26934392. — Inherited from L2.2. Elevated granulosa HSD11B1 in PCOS-IR generates LOCAL intrafollicular hypercortisolism, independent of systemic levels. The BVT.2733 inhibitor reverses the phenotype.
Whirledge SD, Oakley RH, Myers PH, Lydon JP, DeMayo F, Cidlowski JA (2015). "Uterine glucocorticoid receptors are critical for fertility in mice through control of embryo implantation and decidualization." PNAS 112(49):15166-15171. DOI: 10.1073/pnas.1508056112. PMID: 26598704. PMC: PMC4679013. — Uterine-specific GR KO (Pgr-Cre) → subfertility due to implantation defect and aberrant decidualization. GR is not only a PR competitor in endometrium — it is a necessary cofactor for uterine receptivity. The Cidlowski/Whirledge NIH R01-HD103692 program extends this.
Whirledge S, Cidlowski JA (2013). "A role for glucocorticoids in stress-impaired reproduction: beyond the hypothalamus and pituitary." Endocrinology 154(12):4450-4468. DOI: 10.1210/en.2013-1652. PMID: 24064363. — Foundational review. Documents GR expression in: granulosa, theca, corpus luteum, oviduct, luminal and glandular endometrium, decidua, myometrium. Stress does not act "only in the brain" — it acts directly in every reproductive tissue.
Whirledge S, Quermelle KE, Cidlowski JA (2020). "The detrimental effects of stress-induced glucocorticoid exposure on mouse uterine receptivity and decidualization." FASEB J. PMID: 32918762. — Physiologically relevant chronic cortisol (without pharmacologic DEX) → reduces expression of decidualization markers (PRL, IGFBP1), alters the receptivity gene network. Subclinical stress is sufficient.
Kuroda K, Venkatakrishnan R, Salker MS, et al. (Brosens lab, Univ. of Warwick) (2013). "Elevated periimplantation uterine natural killer cell density in human endometrium is associated with impaired corticosteroid signaling in decidualizing stromal cells." J Clin Endocrinol Metab 98(11):4429-4437. DOI: 10.1210/jc.2013-1977. PMC: PMC4207949. — Decidualizing endometrial stromal cells up-regulate HSD11B1 dramatically → local cortisol production → modulation of the uNK compartment. Decidual HSD11B1 failure associated with high uNK and recurrent miscarriage.
Nepomnaschy PA, Welch KB, McConnell DS, Low BS, Strassmann BI, England BG (2006). "Cortisol levels and very early pregnancy loss in humans." PNAS 103(10):3938-3942. DOI: 10.1073/pnas.0511183103. PMID: 16495411. PMC: PMC1533790. — Kaqchikel Mayan study, Guatemala (LATAM, underused in LATAM literature). Elevated urinary cortisol in the 3 peri-conceptional weeks → 90% loss vs 33% with normal cortisol. Probable causality (not only association) due to longitudinal design with sampling 3×/week. Enormous effect size for a single noninvasive biomarker.
Lei W, McIntire R, Sadovsky Y, et al. (2021). "Decidual cell FKBP51–progesterone receptor binding mediates maternal stress–induced preterm birth." PNAS 118(11):e2010282118. DOI: 10.1073/pnas.2010282118. PMID: 33836562. PMC: PMC7980401. — Elegant mechanism: maternal stress ↑ FKBP51 in decidua → FKBP51 binds PR → "functional progesterone withdrawal" without change in serum P4 levels. Women with idiopathic preterm birth show ↑ nuclear FKBP51-PR binding. Fkbp5⁻/⁻ are resistant to stress-induced preterm birth.
Lei W, et al. (2025). "Targeting FKBP51 prevents stress-induced preterm birth." EMBO Molecular Medicine. PMID: 40097636. DOI: 10.1038/s44321-025-00211-9. — 2025 continuation: SAFit2 inhibitor (small-molecule FKBP51 selective) prevents stress-induced preterm birth in a murine model. Demonstrates that the FKBP51-PR axis is druggable and "functional P4 withdrawal by stress" is reversible.
Hewitt SC, Goulding EH, Eddy EM, Korach KS (2007). "FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific." J Clin Invest 117(7):1824-1832. DOI: 10.1172/JCI31622. — Counterweight to FKBP51: FKBP52 (FKBP4) is a POSITIVE PR co-chaperone. Its deficiency generates uterine resistance to P4 → implantation failure with an apparently normal cycle. FKBP4/FKBP5 are the molecular "rheostat" of the PR/GR balance at the cellular level.
Ly LK, Krieger-Burke T, Mahmud A, Wong S, Devlin AS (2024). "Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas." Cell 187(13):3214-3231.e16. DOI: 10.1016/j.cell.2024.05.005. — Inherited from L1.2. Confirms 21-dehydroxylation of biliary cortisol/cortisone → P4/allopregnanolone by Eggerthella lenta + Gordonibacter pamelaeae + H₂ from E. coli. Direct bridge to L2.3: defines the fate of biliary cortisol that escaped GR (via bile) — becoming intestinal endogenous P4 or remaining a substrate for recirculation. The system "knows" what to do with "excess" cortisol.
Jiang Y, Zhang Y, et al. (2025). "Dual Mechanisms of Chronic Stress in Recurrent Pregnancy Loss: Progesterone Deficiency and Inflammatory Amplification." Comprehensive Physiology — Wiley Online Library. DOI: 10.1002/cph4.70063. — 2025 synthesis. Explicitly proposes that in RPL (recurrent pregnancy loss) two mechanisms coexist: (a) P4 deficit (adrenal synthesis competes with ovarian/luteal P4 for cholesterol-pregnenolone) + (b) inflammation amplified by chronic cortisol via NF-κB/Th17. First explicit review of the concept of "stressed luteal phase" as a pathophysiological entity with two parallel arms.

(16 verified sources. Citable DOI/PMID/PMC.)

Base knowledge

The glucocorticoid receptor (GR, NR3C1 gene) and the progesterone receptor (PR, PGR gene) are two members of the Type I steroid nuclear receptor family — together with AR, ER, and MR. The basic chemistry that defines their rivalry is encoded in their shared evolution: PR and GR arise from gene duplication from an ancestral receptor, which left three structural consequences with major functional implications:

Practically identical DNA-binding domain (DBD) (~90% identity). This means that PR and GR recognize almost indistinguishable genomic sequences — the family of inverted hexamers AGAACA-nnn-TGTTCT that constitutes the GRE (glucocorticoid response element) and the PRE (progesterone response element) is essentially the same motif. The distinction "pure GRE vs pure PRE" in genomic practice is minor; most are GRE/PRE hybrids that both receptors can bind.
Ligand-binding domain (LBD) ~55% identical. Enough specificity for each hormone to prefer its cognate receptor, but enough overlap for progesterone to bind GR (Ki ~215 nM vs Kd ~4.2 nM for dexamethasone) and for certain corticoids to bind PR weakly. Progesterone is an endogenous partial antagonist of GR. At mid-high luteal concentrations (serum P4 10-25 ng/mL ≈ 30-80 nM, intraluteal much higher), P4 effectively competes with cortisol for GR in tissues where local cortisol is modest.
Shared transcriptional cofactors. p160 proteins (SRC-1/2/3), CBP/p300, SWI/SNF remodeling complexes, PAF, and SAGA are recruited by both receptors. The cell has a finite pool of co-activators, creating functional competition even when the receptors bind distinct sites. The well-known GR-PR "cross-transcriptional repression" operates both through chromatin co-binding and through sequestration of limiting co-activators.

The 11β-hydroxysteroid dehydrogenase (HSD11B) system modulates this rivalry at the pre-receptor level:

HSD11B2 (HSD11B2 gene, NADP-dependent, exclusive oxidase) converts cortisol → cortisone (inactive). It is the "anti-cortisol guardian" in mineralocorticoid-sensitive tissues (kidney) but also in placenta, decidua during early implantation, and follicular granulosa. Without functional HSD11B2, cortisol invades the mineralocorticoid receptor (AME syndrome) and blocks PR where it should not.
HSD11B1 (HSD11B1 gene, NADPH-dependent, mostly reductase) does the opposite: cortisone → cortisol (active). It predominates in liver, adipose tissue, bone, late decidua, and critically luteinized granulosa and corpus luteum. The corpus luteum makes its own intracellular cortisol from circulating cortisone.

This enzymatic duality creates a system of zones and phases:

Tissue + Phase = dominant HSD11B2 → cortisol expelled, P4 reigns in GR/PR
Tissue + Phase = dominant HSD11B1 → cortisol regenerated locally, occupies GR, modulates response

This is where the key Johannsen 2024 finding enters: the ovary operates with dominant HSD11B2 until the mid-cycle surge, at which point it abruptly reverses to dominant HSD11B1. In other words, granulosa decides to convert from a "cortisol-protected environment" into a "cortisol-permissive environment" exactly when it is about to ovulate. The intrafollicular cortisol that appears does not arrive from outside — it is manufactured locally by reactivating biliary/circulating cortisone.

At the level of the formed corpus luteum, the scenario partially reverses: HSD11B1 remains functional but now HSD11B2 is also present and modulates luteal regression (Albrecht et al. 1996, PMID 8940361 — cited in background). The HSD11B1/HSD11B2 balance in the corpus luteum is dynamic during the luteal phase: early maturation = high HSD11B1 + low HSD11B2 (cortisol-permissive for formation); mid-luteal phase = balance; late luteal phase / regression = HSD11B2 rises (cortisol expelled, prepares luteolysis or, if pregnancy occurs, transition to placenta).

The endometrium follows its own parallel and synchronized script:

Proliferative phase = low HSD11B1, high HSD11B2 → "cortisol-protected" endometrium
Secretory phase / implantation window = decidualizing stromal cells dramatically up-regulate HSD11B1 (Kuroda 2013) → local cortisol production that cooperates with P4 to configure the implantation environment (uNK modulation, angiogenesis, IGFBP1/PRL expression)
Established pregnancy = trophoblastic + decidual HSD11B2 rises strongly to protect the fetus from maternal cortisol

On the corpus luteum specifically: it constitutively expresses GR throughout the luteal phase and, in gestation, throughout pregnancy. The progesterone produced by the corpus luteum acts through an autocrine pathway on its own GR to suppress 20α-HSD (the enzyme that catabolizes P4) — Stocco et al. 1997, PMID 9322971. This is notable: P4 uses GR (not only PR) to sustain itself. Elevated cortisol competes for this site and unlocks 20α-HSD → P4 is catabolized faster → accelerated luteolysis.

The last component of base knowledge: the immunophilins FKBP4 (FKBP52) and FKBP5 (FKBP51). They are co-chaperones that assemble with HSP90 on steroid receptors in their unliganded state, modulating ligand response.

FKBP4 / FKBP52 = PR-ENHANCING co-chaperone. Increases PR affinity and transcriptional efficiency. Its KO generates uterine resistance to progesterone with an apparently normal cycle (Hewitt 2007). It is the "molecular amplifier" of P4.
FKBP5 / FKBP51 = PR and GR INHIBITING co-chaperone. Reduces affinity and retains receptors in the cytoplasm. Its stress-driven overexpression (FKBP5 is a cortisol target via GR — positive loop) produces "functional progesterone withdrawal" without change in serum P4 levels (Lei 2021, PNAS).

The FKBP5 rs1360780 T/T polymorphism (inherited from L2.1) confers increased HPA reactivity + more inducible FKBP51 expression → lower PR efficiency + greater stress sensitivity. This directly connects stress epigenetics with functional resistance to P4. This is one of the concrete molecular explanations for "stress eating your progesterone without your blood test changing."

Findings from recent papers

1. Johannsen 2024 (Hum Reprod 39(3):578-585) — correction and deepening of the L2.2 "Park" finding

The paper that in L2.2 we tentatively attributed to "Park 2023/2024" is actually Johannsen et al. 2024, Claus Yding Andersen's group (Copenhagen). Reports remain intact in content — authorship correction for lab precision.

Precisely confirmed findings:

Intrafollicular concentrations of biologically active cortisol (CBG-free) rise abruptly during the peri-ovulatory hours, reaching levels that would be pathological in other tissues.
The mechanism is NOT cortisol entry from plasma — it is an intracellular enzymatic switch in granulosa: HSD11B2 (dominant in small/medium follicle) falls, HSD11B1 (suppressed in small/medium follicle) rises dramatically with the hCG/LH cascade.
This elevated intrafollicular cortisol is OBLIGATORY for:
- Termination of the peri-ovulatory inflammatory process (COX-2 → PGE2 → follicular rupture cascade)
- Configuration of the luteinized granulosa phenotype (down-regulation of aromatase CYP19A1, up-regulation of StAR, P450scc)
- Transition from the follicular → luteal transcriptional program
GR antagonists (RU486 or mifepristone) block the ovulatory cascade when administered in the peri-LH window.

Paradigmatic implication: "P4-cortisol competition for GR" must be dissected by cycle phase. In the late follicular phase (24-36 h pre-ovulation), the cascade requires GR + P4 co-signaling (P4 is rising, intrafollicular cortisol is rising); the ovary operates with both receptors productively occupied — this is not "competition", it is GR + PR synergy in the ovulatory transition.

Only in the mid-late luteal phase (cycle days 21-26), when luteinized granulosa has stabilized its P4 production program and needs to protect it from catabolism, does the presence of elevated cortisol become a functional antagonist: it unlocks 20α-HSD, competes with P4 for the corpus luteum's self-sustaining GR, and accelerates luteolysis.

This is the core of L2.3: GR does not have "a single function" in the reproductive system. It changes partners depending on the phase. It is a cycle-phase sensor whose biological function is opposite between late follicular and late luteal phases.

2. Wu 2016 + 2023-2024 extension — ovarian HSD11B1 as a local amplifier

Wu 2016 (PMID 26934392, already in lab findings from L2.2) shows that in PCOS-IR, granulosa HSD11B1 is chronically elevated vs normal cycle. This means that the PCOS-IR follicle operates in "permanent cortisol-permissive mode" — it does not wait for the mid-cycle surge to activate HSD11B1; it already has it active. The result: chronic intrafollicular cortisol → local granulosa insulin resistance → ovulatory failure + atresia. The BVT.2733 inhibitor reverses the phenotype in the model.

The 2024 extension (Johannsen): the physiological enzymatic switch does the same thing as PCOS dysfunction — but in the correct window (peri-ovulation) and for hours, not chronically. PCOS-IR can be read as a "physiological switch stuck ON" — the follicle believes it is always peri-ovulating, which creates chronic cortisol, which blocks real ovulation. It is an elegant mechanistic explanation for why hyperandrogenic-anovulatory PCOS is NOT a "stress-inflamed ovary" — it is an "ovary frozen in a peri-ovulatory state by HSD11B1 dysregulation."

3. Whirledge & Cidlowski 2013 + Whirledge 2015 — uterine GR is necessary, not antagonistic

This was revealing to me. The popular narrative ("cortisol blocks P4 in the uterus") is inaccurate as a single model. Whirledge 2015 (PNAS, PMID 26598704) demonstrated that mice with uterus-specific GR KO (Pgr-Cre × GR-floxed) are SUBFERTILE because of implantation defect and decidualization failure. It is not that GR is "always bad" in endometrium — it is necessary for normal uterine receptivity.

Refined model:

Moderate physiological cortisol in peri-implantation endometrium acts via GR to:
- Modulate expression of Galectin-7, claudin-1, HoxA10 (receptivity genes)
- Configure the uterine NK cell (uNK) compartment — number and phenotype
- Cooperate with P4-PR in inducing the decidual program
Chronically elevated cortisol (stress) → dysregulates this cooperation → implantation defect even with normal P4 (Whirledge 2020, PMID 32918762).

Endometrial GR therefore operates as a tension modulator. There is an optimal zone of local cortisol — too low (GR KO) → failure; too high (chronic stress) → failure; middle → correct receptivity. Inverted U-shaped curve (second inverted U of the HPA-HPO axis, parallel to the ovarian one from Gershon 2025 inherited from L2.2).

4. Kuroda/Brosens 2013 — decidual HSD11B1 and the "decidual cortisol gradient"

Decidualizing endometrial stromal cells (DESCs) upregulate HSD11B1 up to 25-50× their basal expression during decidualization. This creates a local cortisol gradient at the implantation site that is not seen in any other area of the body (except liver).

What is this decidual cortisol for?

Modulation of the uNK compartment (cortisol maintains uNK CD56^bright/CD16⁻ — tolerogenic, non-cytotoxic phenotype).
Coordinated induction of controlled angiogenesis genes (balanced VEGF).
Cooperation with P4 in suppression of the Th1/Th17 response (induction of local Treg).

When decidual HSD11B1 fails (recurrent miscarriage cohorts) → elevated uNK density + more cytotoxic phenotype + implantation failure.

When there is chronically elevated systemic cortisol + normal HSD11B1 → the "extra" cortisol saturates the system, unbalances uNK in the other direction, dysregulates angiogenesis → implantation failure by excess, not by deficit.

This reformulates the "stress → miscarriage" model from a simplistic pharmacological view ("cortisol = abortive") into a model of local decidual allostatic load: the endometrium at implantation MUST HAVE active local cortisol, but that cortisol has to come from the physiological decidual switch (HSD11B1 → "ordered" local cortisol) and not from chronic systemic stress ("chaotic" cortisol arriving by diffusion).

5. Lei 2021 + Lei 2025 — FKBP51 as the molecular mediator of stress → "functional progesterone withdrawal"

This is the cleanest mechanism I know for how "psychological stress" translates into "functionally absent P4" without changes in serum levels. Lei 2021 (PNAS, PMID 33836562):

Maternal stress (restraint model in mouse + human idiopathic preterm birth cohort) → ↑ cortisol → GR activation in decidua → ↑ FKBP5 transcription (direct GR target; has GRE in intron 2).
FKBP51 ↑ binds PR in the HSP90 complex → reduces PR sensitivity to P4 → PR functionally deactivated despite normal serum progesterone levels.
Result: PR-mediated decidual transcriptional program (including inflammation suppression, maintenance of myometrial quiescence) fails → preterm birth.

Women with idiopathic preterm birth show ↑ nuclear FKBP51 + ↑ FKBP51-PR binding in decidua, independent of serum progesterone levels.

Fkbp5⁻/⁻ are resistant to stress-induced preterm birth.

Lei 2025 (EMBO Mol Med, PMID 40097636) advances this: the selective inhibitor SAFit2 (small molecule FKBP51) prevents stress-induced preterm birth. FKBP51-PR is a druggable target.

By natural extension — and this is from the lab's critical analysis, not a direct datum from the paper — the same mechanism operates in the pre-implantation luteal phase: chronic stress → ↑ endometrial FKBP51 → ↓ PR sensitivity → silent implantation failure before clinical pregnancy. This fits Nepomnaschy 2006 (Guatemala): elevated urinary cortisol in the 3 peri-conceptional weeks → 90% loss vs 33%. Most of these losses are subclinical, detectable only through the cortisol curve + implantation failure — exactly the phenomenon the FKBP51 model predicts.

6. Hagan/Lange 2019 (NAR PMC6846950) + Diep 2022 (Front Endo PMC9672667) — GR-PR crosstalk at the chromatin level

The most recent GR-PR crosstalk model (studied in breast cancer but mechanistically conserved):

GR and PR share ~50% of their chromatin binding sites in cells expressing both.
At shared sites, the presence of both ligands (P4 + DEX) generates:
- Antagonism in ELF5, GREB1, and other pro-proliferative genes (joint downregulation vs either alone) — GR "consumes" co-activators that PR needs.
- Synergy in SNAI1, STAT5A genes — formation of heterodimeric GR-PR complexes physically bound to DNA.
The antagonism/synergy balance depends on:
- Relative ratio of each receptor in the cell
- Limiting co-activators
- Enhancer epigenetic modification (H3K27ac, H3K4me1)

Translation to luteal phase (Lua Labs extrapolation, not from the direct paper): in luteinized granulosa and decidualizing endometrium, PR and GR co-expression + local cortisol generated by HSD11B1 + ovarian P4 generate the same heterochromatin pattern. The "synergistic" GR+PR genes (IGFBP1, PRL, decidualization) are induced; the "antagonistic" genes (residual proliferation, inflammation) are silenced. Extra chronic systemic cortisol breaks this balance.

7. Devlin/Ly 2024 (Cell, 21-dehydroxylation) — cortisol "not used by GR" has a microbial fate

Bridge to L1.2. Excreted biliary cortisol — which escaped both GR and HSD11B2 — is not lost. In the distal ileum/colon it is converted by Eggerthella lenta + Gordonibacter pamelaeae into progesterone and allopregnanolone via 21-dehydroxylation (Elen_2451-2454 cluster), dependent on H₂ produced by E. coli.

What is new from reading Devlin 2024 through the L2.3 lens: the system knows how to deal with "excess" cortisol. If the progesterobolome is intact, that biliary cortisol is converted into intestinal endogenous P4 → enterohepatic recirculation → partial bypass of ovarian/luteal dependence on P4. It is the endogenous anti-stress buffer of the HPA-HPO axis.

Perimenopausal woman with dysbiosis + broken progesterobolome → biliary cortisol is not converted → cortisol returns to liver through enterohepatic circulation → more total active cortisol → more competition with P4 in GR/PR → more luteal symptoms. This is the full loop that L2.3 closes.

8. Jiang 2025 (Compr Physiol DOI 10.1002/cph4.70063) — the first "two-arm" framework

This 2025 review explicitly articulates what the lab had been synthesizing: in recurrent pregnancy loss (RPL) due to chronic stress, two mechanisms coexist:

(a) "P4 deficit" arm: cholesterol/pregnenolone is diverted toward adrenal cortisol synthesis (adrenal steroidogenesis up-regulated by ACTH); less substrate available for luteal P4 synthesis; P4-PR failure.

(b) "Amplified inflammation" arm: chronic cortisol → Treg/Th17 imbalance → local decidual NF-κB → IL-6, TNF-α, IL-1β; "tolerogenic" cortisol becomes "inflammogenic" through temporal dysregulation (loss of HSD11B1 modulation, high FKBP51).

What Jiang 2025 does not integrate and Lua Labs does (we state this as an original contribution):

(c) "GR as phase sensor" arm: synchronization between the ovarian HSD11B2→HSD11B1 switch and decidual HSD11B1 up-regulation depends on moderate, well-timed cortisol. Chronic stress desynchronizes the switch — the ovary reaches "cortisol-permissive mode" while the endometrium remains in "cortisol-protected mode", or vice versa.

(d) "Microbial-progesterobolomic buffer" arm: biliary cortisol can be converted into intestinal endogenous P4 — an additional buffer that dysbiosis ruins.

Combining (a)+(b)+(c)+(d) = 4-arm model of stressed luteal failure, not 2.

Complete molecular/endocrine mechanism

Core of the L2.3 model: GR changes partners according to cycle phase

                    LATE FOLLICULAR PHASE (days 12-14)
                    [GR = SYNERGISTIC with PR]

Biliary/circulating cortisone → HSD11B1 (UP) → Intrafollicular cortisol ↑↑
                                           ↓
                                     GR activated in granulosa
                                           ↓
        GR + PR co-signaling (P4 rising) → ovulatory cascade:
        - Termination of COX-2/PGE2 inflammation
        - Aromatase down, StAR/CYP11A1 up
        - Reprograms granulosa: follicular → luteinized
                                           ↓
                                     OVULATION + CORPUS LUTEUM FORMATION
                                           
                    ─────────────────────────────────────────

                    EARLY-MID LUTEAL PHASE (days 16-22)
                    [GR = FINE MODULATOR of P4]

Corpus luteum: sustained HSD11B1 + emerging HSD11B2 → moderate local cortisol
                                           ↓
              GR self-sustains P4 (suppresses 20α-HSD → P4 is not catabolized)
                                           ↓
              ENDOMETRIUM: decidual HSD11B1 ↑↑ → local decidual cortisol
                                           ↓
              Decidual GR + decidual PR = decidualization program:
              IGFBP1, PRL, uNK quality, controlled angiogenesis, Treg
                                           ↓
                                     OPTIMAL UTERINE RECEPTIVITY

                    ─────────────────────────────────────────

                    LATE LUTEAL PHASE / IMPLANTATION (days 22-28)
                    [GR = POTENTIAL ANTAGONIST if systemic cortisol ↑]

NORMAL CONTEXT: moderate systemic cortisol, preserved circadian rhythm
   → HSD11B1/HSD11B2 balanced in corpus luteum
   → local P4-PR + cortisol-GR in cooperation
   → Maintenance of luteal phase / implantation / early decidualization

CHRONIC STRESS CONTEXT: systemic cortisol ↑↑, flattened rhythm
   → Cortisol saturates decidual HSD11B2 (finite enzymatic capacity)
   → Cortisol competes for the self-sustaining GR in corpus luteum
       → unlocks 20α-HSD → P4 catabolized → accelerated luteolysis
   → Cortisol activates FKBP5 via GR in decidua
       → FKBP51 ↑ binds PR → "functional P4 withdrawal"
       → decidualization failure with normal serum P4
   → Treg/Th17 imbalance → decidual IL-6/TNF-α/IL-1β
       → inflammatory environment incompatible with implantation
   → Intact excreted biliary cortisol (HSD11B2 inactivated part) →
       IF progesterobolome intact → 21-dehydroxylation → endogenous P4 → buffer
       IF progesterobolome broken → cortisol recirculates → more total cortisol

GR receptor board across reproductive compartments

Compartment	HSD11B1	HSD11B2	GR expression	Physiological role of GR
Small follicular granulosa	low	HIGH	low	Cortisol expelled, does not signal
Pre-ovulatory follicular granulosa	HIGH (post hCG)	low	medium-high	Co-signals with PR (ovulatory cascade)
Luteinized granulosa	HIGH	medium	HIGH	Self-sustains P4 (suppresses 20α-HSD)
Mid corpus luteum	medium	medium	HIGH	Fine modulator of P4 / regression
Late corpus luteum	low	HIGH	HIGH	Prepares luteolysis or gestation
Proliferative endometrium	low	HIGH	low	Cortisol expelled
Secretory endometrium (peri-implantation)	VERY HIGH	medium	HIGH	Decidualization cofactor
Established decidua	HIGH	HIGH	HIGH	Co-signals with PR (maintenance)
Placenta (trophoblast)	low	VERY HIGH	medium	Anti-maternal-cortisol barrier → fetus

Structural lesson: the reproductive system operates with a spatiotemporal mosaic of GR activity. The narrative "cortisol always suppresses reproduction" misses that the body deliberately orchestrates GR-active windows.

The 4 arms of stressed luteal failure (Lua Labs model)

Chronic stress (PSS-4 ≥ 8, ACEs ≥ 4, high caregiving load)
  │
  ├─ Arm A: Substrate-mediated P4 deficit
  │    Chronic ACTH → adrenal hypertrophy → cholesterol/pregnenolone diversion
  │    → luteal P4 falls → insufficient P4-PR
  │
  ├─ Arm B: Amplified inflammation
  │    Chronic cortisol → loss of temporal HSD11B1 modulation →
  │    Treg/Th17 imbalance → NF-κB → decidual IL-6/TNF-α/IL-1β →
  │    anti-implantation inflammatory environment
  │
  ├─ Arm C: GR-phase desynchrony (new Lua Labs mechanism)
  │    Chronic stress flattens cortisol rhythm →
  │    ovarian HSD11B1 and decidual HSD11B1 lose synchrony →
  │    pre-ovulatory granulosa arrives "cold" / decidua arrives "hot" (or vice versa)
  │    → cycle-implantation coupling failure
  │
  └─ Arm D: Collapsed microbial-progesterobolomic buffer
       Dysbiosis + unconverted biliary cortisol →
       cortisol recirculates → more total cortisol → exacerbates Arms A-B-C
       (Lua Labs L1.2 ↔ L2.3 mechanism)

Operational prediction: the number of women with "normal P4 but severe luteal symptoms / subclinical early miscarriage" is enormous and concentrates in profiles with dominant Arms C+D (the least visible in standard blood tests).

The complete L1↔L2 loop closed

Intestinal dysbiosis (perimenopausal, post-antibiotic, low-fiber)
    │
    ├─ ↓ Parabacteroides → ↓ sulfatases → ↓ biliary P4 desulfation
    ├─ ↓ Eggerthella + Gordonibacter → ↓ cortisol→P4 21-dehydroxylation
    └─ ↓ SCFA → ↓ SCFA-modulated vagal afference → PVN-CRH disinhibition
            │
            v
    Sustained chronic cortisol (microbiota-vagus-HPA axis L1.6/L2.1)
            │
            v
    Ovarian + decidual + luteal convergence:
    - Granulosa: dysregulated HSD11B1 ("PCOS-IR" style)
    - Corpus luteum: saturated GR → 20α-HSD unlocked → P4 catabolized
    - Decidua: saturated HSD11B1 → FKBP51 induced → functional P4 withdrawal
    - Biliary cortisol: NOT converted to intestinal P4 (broken loop)
            │
            v
    Symptoms and outcomes:
    - Shortened (<11d) and/or variable luteal phase (CV >12%)
    - Severe luteal symptoms (irritability, insomnia, mood drop d21-28)
    - Subclinical miscarriage (does not reach clinic)
    - Early clinical miscarriage (<10 wk) in chronically stressed women
    - Idiopathic preterm birth (in those who reach pregnancy)

This is the conceptual closure of L1↔L2. It is not "stress affects hormones" — it is the microbiota-vagus-HPA-HPO-decidua axis operating as a single subsystem.

Cross-synthesis with previous findings

Inherited L1.2 connection (progesterobolome — 21-dehydroxylation) — ACTIVATED

Devlin/Ly 2024 (L1.2) + Whirledge 2013/2015 + Lei 2021 (L2.3) close a complete endocrine loop:

The systemic cortisol that saturates the reproductive compartments (ovary, corpus luteum, decidua) and triggers the 4 arms of luteal failure is the same cortisol that, eventually, will be excreted through bile. What happens in the intestine determines whether that cortisol becomes an endogenous buffer (converted to P4/allopregnanolone) or an additional load (actively recirculated).

In a woman with an intact progesterobolome, biliary cortisol functions as a sacrificial substrate: acute stress raises cortisol → saturates systemic HSD11B2 → it is excreted through bile → in the intestine Eggerthella converts it to P4 → enterohepatic reabsorption → endogenous P4 supplements luteal P4 → softens the deficit. It is an elegant evolutionary mechanism: cortisol "consumes its own antagonist" without requiring ovarian effort.

In a woman with a broken progesterobolome (perimenopause with dysbiosis, multiple post-antibiotic states, chronic low-fiber intake, LATAM dietary acculturation L1.4), biliary cortisol remains cortisol → recirculates → raises total levels → all arms of luteal failure are exacerbated.

Inherited L1.6 connection (neurobolome + vagal-tone phenotype) — remains active

L1.6 delivered the "distributed metabolic-neural sub-organ" model where vagal-NTS afference modulates CRH-PVN. L2.3 adds the decidual link: the cortisol that reaches uterus/ovary is the result of the upstream vagal-CRH-HPA cascade. Low vagal-tone phenotype = more tonic CRH-PVN = more chronic cortisol = higher probability of failure in the 4 luteal arms.

Operational prediction: vagal-tone phenotype and dietary-diversity phenotype together predict "stressed luteal phase" (severe luteal symptoms + irregular cycle) better than either separately. vagal-tone phenotype × dietary-diversity phenotype interaction term should be significant.

Inherited L2.1 connection (KNDy + genetic susceptibility) — extended

L2.1 established that FKBP5 rs1360780 T/T confers increased HPA reactivity and susceptibility to FHA + depression. L2.3 now extends this polymorphism to the peripheral compartment:

FKBP5 rs1360780 T/T → more inducible systemic FKBP51 expression → in decidua, more FKBP51-PR binding under chronic stress → more "functional P4 withdrawal."
NR3C1 BclI G/G polymorphism (inherited from L2.1) → hypersensitive GR → greater response to moderate cortisol → potentially greater P4-PR antagonism in the luteal phase.

The L2.1 polymorphisms explain central susceptibility; the same polymorphisms predict peripheral luteal/decidual susceptibility in L2.3. A woman with FKBP5 T/T + dysbiosis + high caregiving load would have an amplified phenotype in all 4 arms simultaneously.

Inherited L2.2 connection (ovarian CRH + inverted U) — refined and corrected

L2.2 reported that pre-ovulatory intrafollicular cortisol is an obligatory physiological signal. L2.3 corrects authorship (Johannsen 2024, not Park) and deepens the mechanism: the HSD11B2 → HSD11B1 switch that produces intrafollicular cortisol is triggered by the hCG/LH cascade and depends on the integrity of the luteinization program.

The ovarian inverted U from Gershon 2025 (L2.2) now has an endometrial sister inverted U (Whirledge 2015): the endometrium needs moderate cortisol for receptivity — too low (GR KO) or too high (chronic stress) → implantation failure.

Emerging model: the HPA-HPO axis operates with two parallel and synchronized inverted U curves — ovarian (CRHR1 theca, HSD11B1 granulosa) + endometrial (decidual GR, decidual HSD11B1). Temporal synchronization between both U curves requires an intact cortisol rhythm. Chronic stress flattens both U curves simultaneously → bifurcation into luteal failure through its 4 arms.

Proposed product/biomarker: "Luteal-Phase Buffer" extension of the HPA-Resilience Stack + Ovarian-Stress Buffer

L2.1 proposed "HPA-Resilience Stack." L2.2 extended it to "Ovarian-Stress Buffer." L2.3 completes it as "Luteal-Phase Buffer" — designed specifically for cycle days 18-28 and women with a silent luteal failure profile.

A conceptual composite indicator of a "stressed luteal phase" can integrate cycle, symptom, perceived-stress, and sleep markers (weight in parentheses):

Luteal phase < 11 days (+25 if present)
Severe luteal symptoms (mood drop, irritability, insomnia, severe breast pain d18-28; scale 0-3 items × 4 = 0-12 → ×2 = 0-25)
PSS-4 last 30d ≥ 8 sustained (+15)
vagal-tone phenotype < lower tercile (+15)
Sleep disruption d18-28 (≥2 fragmented nights/week) (+10)

A composite score ≥ 50 flags a "probably stressed luteal phase" and points toward the Luteal-Phase Buffer recommendations. It is a conceptual research construct, not a diagnostic tool.

Lua Labs Hypotheses

Hypothesis 15 — "GR as a cycle-phase sensor: active cortisol availability in the correct window determines whether the luteal phase matures or aborts"

Statement: In women with active cycles (25-42 years), the probability of an adequate luteal phase (duration ≥ 11 days + absence of severe luteal symptoms + absence of early miscarriage) does NOT depend on absolute serum P4 or cortisol levels, but on the integrity of the temporal HSD11B2→HSD11B1 switch in ovarian granulosa + the HSD11B1 up-regulatory switch in peri-implantation endometrium + the availability of the microbial-progesterobolomic buffer. Chronic stress (PSS-4 ≥ 8 sustained for 90 days) flattens both switches and saturates the buffer, generating a "stressed luteal phase" as a digitally trackable phenotype, independent of serum measurements.

Proposed mechanism:

Ovarian switch (inherited L2.2 + Johannsen 2024): the peri-ovulatory hCG/LH cascade normally activates HSD11B1 in granulosa → obligatory intrafollicular cortisol → luteinization cascade. Chronic stress → temporal HSD11B1 dysregulation (Wu 2016 PCOS-IR style but to a lesser degree) → switch arrives "late" or "incomplete" → suboptimal luteinized granulosa → suboptimal corpus luteum → luteal P4 falls.
Decidual switch (Kuroda 2013 + Whirledge 2015): decidualizing endometrial stromal cells normally up-regulate HSD11B1 → local decidual cortisol gradient that cooperates with P4 → receptivity. Chronic stress → decidual HSD11B1 saturated by systemic cortisol → uNK dysregulation → subclinical implantation failure.
FKBP51 bridge (Lei 2021/2025): chronic stress → GR activated by cortisol → ↑ FKBP51 → FKBP51-PR binding → functional P4 withdrawal without serum change. P4 levels in a test can be perfectly normal while PR does not respond.
Progesterobolomic buffer (Devlin 2024 + L1.2): biliary cortisol normally converted into endogenous P4 by Eggerthella + H₂ — additional buffer. Dysbiosis → broken buffer → cortisol recirculates → exacerbates arms 1-3.
Parallel endometrial inverted U (Whirledge 2015): uterine-GR KO is subfertile → endometrium needs functional GR + moderate cortisol. Chronic stress pushes the system out of the optimal zone.

Confidence: Medium-high for components 1-4 (each link is documented in the cited literature); Medium for the quantitative integration of the 4 arms (the summed 4-arm model is an original Lua Labs synthesis, not tested as such in the literature). High for the qualitative prediction that a composite luteal-phase indicator will separate "adequate" vs "stressed" luteal phase better than serum P4 alone.

How to validate:

With observational cycle-tracking data:
1. Does luteal-phase duration correlate inversely with luteal stress phenotype? (expected: r ≥ -0.30, p < 0.05)
2. Does severity of luteal symptoms (mood drop d18-28, insomnia d22-28) correlate with luteal stress phenotype? (expected: r ≥ 0.40)
3. Do reports of "early miscarriage" or "pregnancy did not progress" in people trying to conceive cluster in luteal stress phenotype ≥ 60? (expected: OR ≥ 3.0)
- Interaction terms:
  - vagal-tone phenotype × PSS-4 (should be significant, p < 0.10)
  - dietary-diversity phenotype × PSS-4 (should be significant, p < 0.10)
  - vagal-tone phenotype × dietary-diversity phenotype (should be significant, p < 0.10)
- Phase analysis: compare mood d18-28 vs d2-12 within the same person, stratifying by luteal stress phenotype
With formal study:
- n ≥ 150, 25-42 years, trying to conceive, prospective 12 cycles
- Measure salivary cortisol 4×/day d20-26 + serum P4 d21 + baseline AMH + 16S microbiota test
- Outcome: conception rate + subclinical miscarriage rate (detectable urinary hCG that did not progress)
- Stratification by: luteal stress phenotype, FKBP5 rs1360780, NR3C1 BclI

Limitations:

Weakest link 1: in vivo quantification of the ovarian/decidual HSD11B1 switch is not accessible without biopsy; in practice only indirect proxies can be followed. Causal validation requires an animal model or a cohort with endometrial biopsy (specialized reproductive clinic).
Weakest link 2: the "4 summed arms" model is integrative. It is plausible that certain arms dominate in subgroups (e.g., arm D — microbial buffer — dominates in perimenopause; arm A — P4 substrate — dominates in young ovulatory women under high stress; arm B — amplified inflammation — dominates in RPL with underlying autoimmunity; arm C — GR-phase desynchrony — dominates in night work + jet lag).
Confounders: reproductive age, BMI, thyroid autoimmunity (L3), prior contraceptive use, hormonal contraceptives, number of births. Multivariable models are mandatory.
Risk of overgeneralization: high luteal stress phenotype in a woman not trying to conceive does not imply "infertility" — it implies "less stable luteal phase." Communicate carefully to avoid medicalizing physiological variability.

Candidate formulation "Luteal-Phase Buffer"

Compounds (food-based + behavioral, tiered by intensity):

Level 1 — foundational nutrition (whole cycle, luteal emphasis):

Magnesium (300-400 mg/day) — P4 synthesis cofactor, calibrates GR. Sources: pumpkin seeds, pure cacao, almonds, spinach, black beans.
Vitamin B6 (natural P5P) — cofactor for P4 + 5-HT + GABA. Sources: banana, chickpea, tuna, potato, avocado.
Zinc (10-15 mg) — ovarian HSD cofactor + decidual immunomodulator. Sources: pumpkin seeds, seafood, black beans, lentils.
Food-based vitamin C (200-500 mg) — balanced adrenal synthesis cofactor + granulosa antioxidant. Sources: kiwi, chile, strawberry, guava, citrus.

Level 2 — specific HPA / GR / progesterobolome modulation:

Glycine (3 g pre-sleep from foods or bone broth) — improves nocturnal HRV + GABA-A modulator. Sources: bone broth, gelatin, chicken with skin, chia/hemp seeds.
L-theanine (200 mg from matcha or concentrated green tea) — reduces sympathetic theca/granulosa tone.
Tryptophan + prefrontal access: eat tryptophan-proteins + slow carbohydrate at dinner → 5-HT → melatonin → better cortisol rhythm the next day.
Diversified fermentable fiber (≥ 30 g/day) — support for progesterobolome + estrobolome + neurobolome. Emphasis: nopal, black/pinto beans, chia, flaxseed, natural inulin (onion, garlic, artichoke).
Traditional LATAM fermented food (1 serving/day, ideally L. plantarum-rich: pozol, tejuino, sour atole) — inherited from L1.4. Supports buffer.

Level 3 — specific luteal protocol (days 18-28):

Alcohol restriction d18-28 (raises nocturnal cortisol, damages HRV).
Post-noon caffeine restriction d22-28 (amplifies evening cortisol, particularly in CYP1A2 slow metabolizers).
Regular sleep 22:30-06:30 (chronobiological training — the luteal window is sensitive to circadian desynchrony).
4-6 cpm breathing 5 min/day (efferent vagal tone).
Morning sunlight 10 min in the first hour post-waking (resynchronizes cortisol rhythm).
Exercise: prioritize Z2/Z3 zone d18-28 (sustained high intensity amplifies cortisol).

Target population:

Carmen (47, perimenopause) — maximum priority. Combination of low vagal-tone phenotype + probably low dietary-diversity phenotype + prominent luteal symptoms + progressive luteal-phase shortening = expected luteal stress phenotype ≥ 60 profile.
Sofía (28, active cycle) — case of "stressed luteal phase in a healthy young woman"; typically caregiving load + demanding work + cyclic anxiety d18-26. Expected luteal stress phenotype 40-60.
Valentina (19, possible PCOS) — PCOS variant of luteal phase (when she ovulates) usually presents with elevated granulosa HSD11B1 (Wu 2016 model). Luteal-Phase Buffer applies with emphasis on magnesium + inositol + L-theanine.
Rosa (55, postmenopause) — does not apply directly (no cycle). The buffer will be reformulated in line L8 (DHEA/adrenopause).

Complementary mechanisms:

Magnesium + B6 → P4 synthesis + GABA-A cofactors
Glycine + L-theanine → nocturnal vagal tone → improved cortisol rhythm
Fiber + LATAM fermented food → progesterobolome → biliary cortisol buffer
Sleep + morning sunlight → cortisol chronobiology
Alcohol/caffeine restriction d18-28 → does not amplify arm C
4-6 cpm breathing → efferent vagus → modulated CRH-PVN
6 complementary mechanisms acting on the 4 arms of luteal failure, without redundant overlap.

Regulatory status: 100% food-based + behavioral. Zero pharmacological supplement. GRAS. Does not require prescription, is not a medical claim.

Requires validation:

Cohort validation: n ≥ 100 participants adopting the Luteal-Phase Buffer for 6 months vs matched control by baseline luteal stress phenotype. Compare Δ luteal-phase duration + Δ luteal symptom severity.
Eventual formal validation: small cross-over RCT in reproductive clinic with objective outcomes (serum P4 d21, AMH, salivary cortisol d22-26).